Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 242

1.

Adenovirus Isolated From a Cat Is Related to Human Adenovirus 1.

Ongrádi J, Chatlynne LG, Tarcsai KR, Stercz B, Lakatos B, Pring-Åkerblom P, Gooss D Sr, Nagy K, Ablashi DV.

Front Microbiol. 2019 Jun 25;10:1430. doi: 10.3389/fmicb.2019.01430. eCollection 2019.

PMID:
31293556
Free PMC Article
2.

K21 Compound, a Potent Antifungal Agent: Implications for the Treatment of Fluconazole-Resistant HIV-Associated Candida Species.

John CN, Abrantes PMDS, Prusty BK, Ablashi DV, Africa CWJ.

Front Microbiol. 2019 May 24;10:1021. doi: 10.3389/fmicb.2019.01021. eCollection 2019.

3.

Human Herpesvirus 6 and Malignancy: A Review.

Eliassen E, Lum E, Pritchett J, Ongradi J, Krueger G, Crawford JR, Phan TL, Ablashi D, Hudnall SD.

Front Oncol. 2018 Nov 13;8:512. doi: 10.3389/fonc.2018.00512. eCollection 2018. Review.

4.

KIR2DL4-HLAG interaction at human NK cell-oligodendrocyte interfaces regulates IFN-γ-mediated effects.

Banerjee PP, Pang L, Soldan SS, Miah SM, Eisenberg A, Maru S, Waldman A, Smith EA, Rosenberg-Hasson Y, Hirschberg D, Smith A, Ablashi DV, Campbell KS, Orange JS.

Mol Immunol. 2018 Nov 24. pii: S0161-5890(18)30835-6. doi: 10.1016/j.molimm.2018.09.027. [Epub ahead of print]

PMID:
30482463
5.

Active HHV-6 Infection of Cerebellar Purkinje Cells in Mood Disorders.

Prusty BK, Gulve N, Govind S, Krueger GRF, Feichtinger J, Larcombe L, Aspinall R, Ablashi DV, Toro CT.

Front Microbiol. 2018 Aug 21;9:1955. doi: 10.3389/fmicb.2018.01955. eCollection 2018.

6.

Children infected by human herpesvirus 6B with febrile seizures are more likely to develop febrile status epilepticus: A case-control study in a referral hospital in Zambia.

Tembo J, Chandwe K, Kabwe M, Chilufya M, Ciccone O, Mpabalwani E, Ablashi D, Zumla A, Chen T, Bates M.

J Med Virol. 2018 Nov;90(11):1757-1764. doi: 10.1002/jmv.25269. Epub 2018 Aug 13.

PMID:
30011348
7.

Lymphoproliferative Syndromes Associated with Human Herpesvirus-6A and Human Herpesvirus-6B.

Eliassen E, Krueger G, Luppi M, Ablashi D.

Mediterr J Hematol Infect Dis. 2018 May 1;10(1):e2018035. doi: 10.4084/MJHID.2018.035. eCollection 2018. Review.

8.

Copy Number Heterogeneity, Large Origin Tandem Repeats, and Interspecies Recombination in Human Herpesvirus 6A (HHV-6A) and HHV-6B Reference Strains.

Greninger AL, Roychoudhury P, Makhsous N, Hanson D, Chase J, Krueger G, Xie H, Huang ML, Saunders L, Ablashi D, Koelle DM, Cook L, Jerome KR.

J Virol. 2018 Apr 27;92(10). pii: e00135-18. doi: 10.1128/JVI.00135-18. Print 2018 May 15.

9.

Possible chromosomal and germline integration of human herpesvirus 7.

Prusty BK, Gulve N, Rasa S, Murovska M, Hernandez PC, Ablashi DV.

J Gen Virol. 2017 Feb;98(2):266-274. doi: 10.1099/jgv.0.000692.

PMID:
28284243
10.

Roseolovirus-associated encephalitis in immunocompetent and immunocompromised individuals.

Ongrádi J, Ablashi DV, Yoshikawa T, Stercz B, Ogata M.

J Neurovirol. 2017 Feb;23(1):1-19. doi: 10.1007/s13365-016-0473-0. Epub 2016 Aug 18. Review.

11.

Anti-herpesviral effects of a novel broad range anti-microbial quaternary ammonium silane, K21.

Gulve N, Kimmerling K, Johnston AD, Krueger GR, Ablashi DV, Prusty BK.

Antiviral Res. 2016 Jul;131:166-73. doi: 10.1016/j.antiviral.2016.05.004. Epub 2016 May 12.

PMID:
27181377
12.

Classification of HHV-6A and HHV-6B as distinct viruses.

Ablashi D, Agut H, Alvarez-Lafuente R, Clark DA, Dewhurst S, DiLuca D, Flamand L, Frenkel N, Gallo R, Gompels UA, Höllsberg P, Jacobson S, Luppi M, Lusso P, Malnati M, Medveczky P, Mori Y, Pellett PE, Pritchett JC, Yamanishi K, Yoshikawa T.

Arch Virol. 2014 May;159(5):863-70. doi: 10.1007/s00705-013-1902-5. Epub 2013 Nov 6. Review.

13.

Persistent human herpesvirus-6 infection in patients with an inherited form of the virus.

Pantry SN, Medveczky MM, Arbuckle JH, Luka J, Montoya JG, Hu J, Renne R, Peterson D, Pritchett JC, Ablashi DV, Medveczky PG.

J Med Virol. 2013 Nov;85(11):1940-6. doi: 10.1002/jmv.23685. Epub 2013 Jul 25.

14.

Complete Genome Sequence of Early Passaged Human Herpesvirus 6A (GS Strain) Isolated from North America.

Gravel A, Ablashi D, Flamand L.

Genome Announc. 2013 Jun 13;1(3). pii: e00012-13. doi: 10.1128/genomeA.00012-13.

15.

Transfer factor: an overlooked potential for the prevention and treatment of infectious diseases.

Viza D, Fudenberg HH, Palareti A, Ablashi D, De Vinci C, Pizza G.

Folia Biol (Praha). 2013;59(2):53-67. Review.

16.

Mapping the telomere integrated genome of human herpesvirus 6A and 6B.

Arbuckle JH, Pantry SN, Medveczky MM, Prichett J, Loomis KS, Ablashi D, Medveczky PG.

Virology. 2013 Jul 20;442(1):3-11. doi: 10.1016/j.virol.2013.03.030. Epub 2013 May 4.

17.

Development of a human herpesvirus 6 species-specific immunoblotting assay.

Higashimoto Y, Ohta A, Nishiyama Y, Ihira M, Sugata K, Asano Y, Peterson DL, Ablashi DV, Lusso P, Yoshikawa T.

J Clin Microbiol. 2012 Apr;50(4):1245-51. doi: 10.1128/JCM.05834-11. Epub 2012 Jan 25.

18.

Chromosomally integrated human herpesvirus 6: questions and answers.

Pellett PE, Ablashi DV, Ambros PF, Agut H, Caserta MT, Descamps V, Flamand L, Gautheret-Dejean A, Hall CB, Kamble RT, Kuehl U, Lassner D, Lautenschlager I, Loomis KS, Luppi M, Lusso P, Medveczky PG, Montoya JG, Mori Y, Ogata M, Pritchett JC, Rogez S, Seto E, Ward KN, Yoshikawa T, Razonable RR.

Rev Med Virol. 2012 May;22(3):144-55. doi: 10.1002/rmv.715. Epub 2011 Nov 4. Review.

19.

Review Part 3: Human herpesvirus-6 in multiple non-neurological diseases.

Ablashi DV, Devin CL, Yoshikawa T, Lautenschlager I, Luppi M, Kühl U, Komaroff AL.

J Med Virol. 2010 Nov;82(11):1903-10. doi: 10.1002/jmv.21860. Review. No abstract available.

PMID:
20872717
20.

Serological and virological investigation of the role of the herpesviruses EBV, CMV and HHV-6 in post-infective fatigue syndrome.

Cameron B, Flamand L, Juwana H, Middeldorp J, Naing Z, Rawlinson W, Ablashi D, Lloyd A.

J Med Virol. 2010 Oct;82(10):1684-8. doi: 10.1002/jmv.21873.

PMID:
20827765
21.

Review part 2: Human herpesvirus-6 in central nervous system diseases.

Yao K, Crawford JR, Komaroff AL, Ablashi DV, Jacobson S.

J Med Virol. 2010 Oct;82(10):1669-78. doi: 10.1002/jmv.21861. Review. No abstract available.

22.

Review, part 1: Human herpesvirus-6-basic biology, diagnostic testing, and antiviral efficacy.

Flamand L, Komaroff AL, Arbuckle JH, Medveczky PG, Ablashi DV.

J Med Virol. 2010 Sep;82(9):1560-8. doi: 10.1002/jmv.21839. Review. No abstract available.

PMID:
20648610
23.

Human herpesvirus-6 in patients with Crohn's disease.

Sura R, Gavrilov B, Flamand L, Ablashi D, Cartun R, Colombel JF, Van Kruiningen HJ.

APMIS. 2010 May;118(5):394-400. doi: 10.1111/j.1600-0463.2010.02613.x.

PMID:
20477816
24.

Quantitative HHV-6B antigenemia test for the monitoring of transplant patients.

Loginov R, Karlsson T, Höckerstedt K, Ablashi D, Lautenschlager I.

Eur J Clin Microbiol Infect Dis. 2010 Jul;29(7):881-6. doi: 10.1007/s10096-010-0923-1. Epub 2010 Apr 21.

PMID:
20407819
25.

The latent human herpesvirus-6A genome specifically integrates in telomeres of human chromosomes in vivo and in vitro.

Arbuckle JH, Medveczky MM, Luka J, Hadley SH, Luegmayr A, Ablashi D, Lund TC, Tolar J, De Meirleir K, Montoya JG, Komaroff AL, Ambros PF, Medveczky PG.

Proc Natl Acad Sci U S A. 2010 Mar 23;107(12):5563-8. doi: 10.1073/pnas.0913586107. Epub 2010 Mar 8.

26.

Serum cytokine levels in postinfective fatigue syndrome.

Cameron B, Hirschberg DL, Rosenberg-Hassan Y, Ablashi D, Lloyd AR.

Clin Infect Dis. 2010 Jan 15;50(2):278-9. doi: 10.1086/649546. No abstract available.

PMID:
20034348
27.

Summary of the 6th International Conference on HHV-6 and -7.

Komaroff AL, Ablashi D, Jacobson S.

Herpes. 2008 Nov;15(2):36-8.

PMID:
19856547
28.

HHV-6 Special section. Introduction.

Ablashi D, Jacobson S, Pellett P; Program Committee Co-chairs.

J Clin Virol. 2009 Sep;46(1):9. doi: 10.1016/j.jcv.2009.05.012. Epub 2009 Jun 12. No abstract available.

29.

HHV-6A infection induces expression of HERV-K18-encoded superantigen.

Tai AK, Luka J, Ablashi D, Huber BT.

J Clin Virol. 2009 Sep;46(1):47-8. doi: 10.1016/j.jcv.2009.05.019. Epub 2009 Jun 7.

PMID:
19505843
30.

Multicenter comparison of PCR assays for detection of human herpesvirus 6 DNA in serum.

Flamand L, Gravel A, Boutolleau D, Alvarez-Lafuente R, Jacobson S, Malnati MS, Kohn D, Tang YW, Yoshikawa T, Ablashi D.

J Clin Microbiol. 2008 Aug;46(8):2700-6. doi: 10.1128/JCM.00370-08. Epub 2008 Jun 11. Erratum in: J Clin Microbiol. 2009 Feb;47(2):519.

31.

Highlights from 5th International Conference on HHV-6 and -7.

Komaroff AL, Jacobson S, Ablashi DV, Yamanishi K.

Herpes. 2006 Nov;13(3):81-2.

PMID:
17147913
32.

Cell mediated immunity to meet the avian influenza A (H5N1) challenge.

Pizza G, Amadori M, Ablashi D, De Vinci C, Viza D.

Med Hypotheses. 2006;67(3):601-8. Epub 2006 Apr 17.

PMID:
16603322
33.

A randomized clinical trial of valacyclovir in multiple sclerosis.

Friedman JE, Zabriskie JB, Plank C, Ablashi D, Whitman J, Shahan B, Edgell R, Shieh M, Rapalino O, Zimmerman R, Sheng D.

Mult Scler. 2005 Jun;11(3):286-95.

PMID:
15957509
34.

Human herpesvirus 8 infection among various population groups in southern Israel.

Margalith M, Chatlynne LG, Fuchs E, Owen C, Lee CR, Yermiyahu T, Whitman JE, Ablashi DV.

J Acquir Immune Defic Syndr. 2003 Dec 15;34(5):500-5.

PMID:
14657761
35.

Human herpesvirus-6: a short review of its biological behavior.

Krueger GR, Ablashi DV.

Intervirology. 2003;46(5):257-69. Review.

PMID:
14555846
36.

Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donors.

Pellett PE, Wright DJ, Engels EA, Ablashi DV, Dollard SC, Forghani B, Glynn SA, Goedert JJ, Jenkins FJ, Lee TH, Neipel F, Todd DS, Whitby D, Nemo GJ, Busch MP; Retrovirus Epidemiology Donor Study.

Transfusion. 2003 Sep;43(9):1260-8.

PMID:
12919429
37.

Editorial comment: HHV-6 infection in patients with HIV and other diseases: current status.

Ablashi DV.

AIDS Read. 1999 May-Jun;9(3):200-1. No abstract available.

PMID:
12728906
38.

Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases.

Ablashi DV, Chatlynne LG, Whitman JE Jr, Cesarman E.

Clin Microbiol Rev. 2002 Jul;15(3):439-64. Review.

39.

Dynamics of infection with human herpesvirus-6 in EBV-negative infectious mononucleosis: data acquisition for computer modeling.

Krueger GR, Bertram G, Ramon A, Koch B, Ablashi DV, Brandt ME, Wang G, Buja LM.

In Vivo. 2001 Sep-Oct;15(5):373-80.

PMID:
11695232
40.

Antibodies to human herpesvirus 8 latent and lytic antigens in blood donors and potential high-risk groups in Sweden: variable frequencies found in a multicenter serological study.

Enbom M, Sheldon J, Lennette E, Schulz T, Ablashi DV, Neipel F, Biberfeld P, Carlberg H, Ljungman P, Nilsson A, Söderström T, Wadström J, Linde A.

J Med Virol. 2000 Dec;62(4):498-504.

PMID:
11074479
41.

Lack of serologic association of human herpesvirus-8 (KSHV) in patients with monoclonal gammopathy of undetermined significance with and without progression to multiple myeloma.

Ablashi DV, Chatlynne L, Thomas D, Bourboulia D, Rettig MB, Vescio RA, Viza D, Gill P, Kyle RA, Berenson JR, Whitman JE.

Blood. 2000 Sep 15;96(6):2304-6.

42.

Human herpesvirus type 8 in HIV-infected patients with interstitial pneumonitis.

Müller A, Franzen C, Klussmann P, Wagner M, Diehl V, Fätkenheuer G, Salzberger B, Ablashi DV, Krueger GR.

J Infect. 2000 May;40(3):242-7.

PMID:
10908018
43.

Persistent human herpesvirus 8 viremia associated with coinfection with human T-cell lymphotropic virus type I and myelofibrosis.

Engels EA, Eastman H, Ablashi DV, Wilks RJ, Braham J, Manns A.

J Acquir Immune Defic Syndr. 2000 Mar 1;23(3):283-6. No abstract available.

PMID:
10839667
44.

Human herpesvirus type 8 in salivary gland tumors.

Klussmann JP, Müller A, Wagner M, Guntinas-Lichius O, Jungehuelsing M, Sloots T, Ablashi DV, Krueger GR.

J Clin Virol. 2000 May;16(3):239-46.

PMID:
10738142
45.

Characterization of the human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) oncogene, kaposin (ORF K12).

Muralidhar S, Veytsmann G, Chandran B, Ablashi D, Doniger J, Rosenthal LJ.

J Clin Virol. 2000 May;16(3):203-13.

PMID:
10738139
46.

Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients.

Ablashi DV, Eastman HB, Owen CB, Roman MM, Friedman J, Zabriskie JB, Peterson DL, Pearson GR, Whitman JE.

J Clin Virol. 2000 May;16(3):179-91.

PMID:
10738137
47.

Seroprevalence of human herpesvirus-8 (HHV-8) in countries of Southeast Asia compared to the USA, the Caribbean and Africa.

Ablashi D, Chatlynne L, Cooper H, Thomas D, Yadav M, Norhanom AW, Chandana AK, Churdboonchart V, Kulpradist SA, Patnaik M, Liegmann K, Masood R, Reitz M, Cleghorn F, Manns A, Levine PH, Rabkin C, Biggar R, Jensen F, Gill P, Jack N, Edwards J, Whitman J, Boshoff C.

Br J Cancer. 1999 Nov;81(5):893-7.

48.

Risk of transfusion-associated transmission of human herpesvirus 8.

Engels EA, Eastman H, Ablashi DV, Wilks RJ, Braham J, Manns A.

J Natl Cancer Inst. 1999 Oct 20;91(20):1773-5. No abstract available.

PMID:
10528029
49.

Human herpesvirus 8 cellular immune responses in homosexual men.

Strickler HD, Goedert JJ, Bethke FR, Trubey CM, O'Brien TR, Palefsky J, Whitman JE, Ablashi D, Zeichner S, Shearer GM.

J Infect Dis. 1999 Nov;180(5):1682-5.

PMID:
10515832
50.

Seroepidemiology of Kaposi's sarcoma-associated herpesvirus (KSHV).

Chatlynne LG, Ablashi DV.

Semin Cancer Biol. 1999 Jun;9(3):175-85. Review.

PMID:
10343069

Supplemental Content

Loading ...
Support Center